Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Markets & Finance

B of A Frowns on Amgen-Immunex Merger

Bank of America says that an acquisition of Immunex (AMGN) by Amgen (AMGN) would make strategic sense, but not financial sense, for Amgen.

Analyst Eric Ende says a stock and cash deal would be mostly in accordance with management's public statements about a potential acquisition. He says the acquisition would meet five out of the six criteria set by management, but it appears dilutive, thus missing the most important criteria. Also it would shift Amgen's focus away from its launch of Aranesp.

blog comments powered by Disqus